Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001753926-24-001976
Filing Date
2024-11-20
Accepted
2024-11-20 16:06:55
Documents
1
Group Members
SMS REVOCABLE TRUST

Document Format Files

Seq Description Document Type Size
1 SC 13G/A g084531_sc13ga.htm SC 13G/A 47296
  Complete submission text file 0001753926-24-001976.txt   48852
Mailing Address C/O SLOAN CAPITAL COMPANIES 4734 25TH AVENUE NE SEATTLE WA 98105
Business Address
SLOAN STUART M (Filed by) CIK: 0001215280 (see all company filings)

Type: SC 13G/A

Mailing Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080
Business Address 201 HASKINS WAY SUITE 230 SOUTH SAN FRANCISCO CA 94080 650-407-2376
CERO THERAPEUTICS HOLDINGS, INC. (Subject) CIK: 0001870404 (see all company filings)

EIN.: 871088814 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92943 | Film No.: 241480359
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)